Buy (150 RUB)
Generate QR code
Open Access
Subscription or Fee Access
Papillary fibroelastoma of the aortic valve as a cause of acute coronary syndrome
https://doi.org/10.33667/2078-5631-2024-14-21-25
Abstract
Papillary fibroelastomas represent the second most common group of heart tumors, second only to myxoma. In most patients, the disease is asymptomatic, however, in the case of clinical manifestations, the most common are: embolic syndrome with the development of acute cerebrovascular accident, myocardial infarction. Papillary fibroelastoma is a benign tumor growing from endocardial cells, affecting mainly cardiac valves. To date, echocardiography performed by transthoracic and transesophageal access remains the most accessible method for tumor imaging. The main method of treatment of papillary fibroelastoma is surgery. The prognosis is usually favorable. We present a clinical case of papillary fibroelastoma in a 58-year-old man complicated by type 2 myocardial infarction.
About the Authors
N. E. Pletnev
Botkin Hospital
Russian Federation
Russian Federation
Pletnev Nikita E. - anesthesiologist-reanimatologist at Dept of Anesthesiology and Resuscitation.
Moscow
I. M. Antonov
Botkin Hospital
Russian Federation
Russian Federation
Antonov Ivan M. - PhD Med, anesthesiologist-reanimatologist, head of Dept of Anesthesiology and Resuscitation.
Moscow
I. A. Libov
Botkin Hospital; Russian Medical Academy of Continuing Professional Education
Russian Federation
Russian Federation
Libov Igor A. - PhD Med, senior researcher RMACPE, cardiologist Botkin Hospital.
Moscow
A. G. Komarova
Botkin Hospital
Russian Federation
Russian Federation
Komarova Anna G. - PhD Med, cardiologist, deputy chief physician for medical affairs.
Moscow
E. P. Rodionov
Botkin Hospital; Russian Medical Academy of Continuing Professional Education
Russian Federation
Russian Federation
Rodionov Evgeniy P. - PhD Med, anesthesiologist-reanimatologist, deputy chief physician for medical affairs (anesthesiology and resuscitation) Botkin Hospital, associate professor at Dept of Anesthesiology and Emergency Medicine RMACPE.
Moscow
V. G. Alekseev
Botkin Hospital
Russian Federation
Russian Federation
Alekseev Vladimir G. - DM Sci (habil.), professor, general practitioner.
Moscow
References
1. Gowda RM, Khan IA, Nair CK. et al. Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases. Am Heart. J. 2003; 146: 404–10. DOI: 10.1016/S0002–8703(03)00249–7
2. Tyebally S, Chen D, Bhattacharyya S, Mughrabi A, Hussain Z, Manisty C, Westwood M, Ghosh AK, Guha A. Cardiac Tumors: JACC Cardio Oncology State-ofthe-Art Review. JACC Cardio Oncol. 2020 Jun 16; 2 (2): 293–311. DOI: 10.1016/j.jaccao.2020.05.009. PMID: 34396236. PMCID: PMC 8352246.
3. Sun JP, Asher CR, Yang XS. et al. Clinical and echocardiographic characteristics of papillary Fibroelastomas. Circulation. 2001; 103: 2687–93. DOI: 10.1161/01.CIR.103.22.2687
4. Saad RS, Galvis CO, Bshara W, Liddicoat J, Dabbs DJ. Pulmonary valve papillary fibroelastoma. A case report and review of the literature. Arch. Pathol. Lab. Med. 2001 Jul; 125 (7): 933–4. DOI: 10.5858/2001–125–0933-PVPF. PMID: 11419980.
5. K. Thygesen, J. S. Alpert, A. S. Jaffe. et al. For the Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction Fourth Universal Definition of Myocardial Infarction (2018) J. Am. Coll. Cardiol. 2018; 72: 2231–2264.
6. Sandoval Y, Jaffe AS. Type 2 Myocardial Infarction: JACC Review Topic of the Week. J. Am. Coll. Cardiol. 2019 Apr 16; 73 (14): 1846–1860. DOI: 10.1016/j.jacc.2019.02.018. PMID: 30975302.
7. Zoltowska DM, Sadic E, Becoats K, Ghetiya S, Ali AA, Sattiraju S, Missov E. Cardiac papillary fibroelastoma. J. Geriatr. Cardiol. 2021 May 28; 18 (5): 346–351. DOI: 10.11909/j.issn.1671–5411.2021.05.009. PMID: 34149823; PMCID: PMC 8185441.
8. Fishbein MC, Ferrans VJ, Roberts WC. Endocardial papillary elastofibromas. Histologic, histochemical, and electron microscopical findings. Arch Pathol. 1975 Jun; 99 (6): 335–41. PMID: 1088858.
9. Baikoussis N. G., Dedeilias P., Argiriou M., Argiriou O., Vourlakou C., Prapa E., Charitos C. Cardiac papillary fibroelastoma; when, how, why? Ann Card. Anaesth. 2016; 19: 162–165. DOI: 10.4103/0971–9784.173040. PMID: 26750694; PMCID: PMC 4900378.
10. Mariscalco G., Bruno V. D., Borsani P., Dominici C., Sala A. Papillary fibroelastoma: insight to a primary cardiac valve tumor. J. Card. Surg. 2010; 25: 198–205. DOI: 10.1111/j.1540–8191.2009.00993.x. Epub 2010 Feb 9 PMID: 20149002.
11. Chau ATN, Nguyen QH, Pham HN, Vo M, Huynh BD, Pham NHN, Tran VN, Phan V, Ha QD, Pham D, Pham T, Do D, Tran P. Cardiac papillary fibroelastoma as a cause of acute coronary syndrome. J. Cardiol. Cases. 2022 Aug 22; 26 (5): 379–382. DOI: 10.1016/j.jccase.2022.08.002. PMID: 36312774; PMCID: PMC 9606295.
Review
For citations:
Pletnev N.E., Antonov I.M., Libov I.A., Komarova A.G., Rodionov E.P., Alekseev V.G. Papillary fibroelastoma of the aortic valve as a cause of acute coronary syndrome. Medical alphabet. 2024;(14):21-25. (In Russ.) https://doi.org/10.33667/2078-5631-2024-14-21-25
Views:
383
Email this article 